Evaluation and Workup for Buffalo Hump
Screen all patients with buffalo hump for Cushing's syndrome using a 1 mg overnight dexamethasone suppression test, obtain imaging to characterize the tissue composition, and assess for metabolic comorbidities including diabetes, hypertension, and hyperlipidemia, as buffalo hump may represent a visible marker of systemic metabolic disease rather than isolated lipomatosis.
Initial Clinical Assessment
Focus your history and physical examination on identifying:
- Signs of hypercortisolism: Recent substantial weight gain, central obesity, facial plethora, proximal muscle weakness, easy bruising, purple striae, and hypertension 1, 2
- HIV status and antiretroviral therapy: While historically associated with protease inhibitors, buffalo hump occurs in HIV-negative patients and is not exclusive to those on antiretroviral therapy 3, 4
- Metabolic disease burden: Document presence of obesity (BMI), hypertension, diabetes, and hyperlipidemia—these conditions are notably more prevalent in patients with buffalo hump than in the general population 4
- Functional impairment: Assess neck extension mobility and any discomfort from the mass 5, 6
Biochemical Workup
Mandatory Screening for Cushing's Syndrome
All patients require evaluation for autonomous cortisol secretion:
- 1 mg overnight dexamethasone suppression test is the preferred initial screening test 1, 2
- Administer 1 mg dexamethasone at 11 PM; measure serum cortisol at 8 AM
- Cortisol >5.0 µg/dL suggests subclinical Cushing's syndrome 2
- If abnormal, confirm with a second test (e.g., 2-day low-dose dexamethasone suppression test or 24-hour urinary free cortisol) 2
- Check ACTH and DHEA-S levels to support the diagnosis 2
Critical caveat: Eight HIV-positive patients with buffalo hump showed normal cortisol suppression and no hypercortisolism 3, and the condition can occur without Cushing's syndrome. However, given that buffalo hump is a classic physical finding of Cushing's syndrome, screening remains mandatory to avoid missing this diagnosis 7.
Metabolic Screening
Given the strong association with metabolic disease 4:
- Fasting glucose or HbA1c (66.7% prevalence of diabetes in one cohort)
- Lipid panel (75% prevalence of hyperlipidemia)
- Blood pressure measurement (66.7% prevalence of hypertension)
Consider screening even in patients without known metabolic disease, as buffalo hump may be the presenting sign 4.
Additional Hormonal Testing (If Indicated)
- Aldosterone-to-renin ratio: Only if hypertension and/or hypokalemia present 1, 2
- Plasma metanephrines or 24-hour urinary metanephrines: Only if signs/symptoms of catecholamine excess or if imaging suggests pheochromocytoma 1, 2
- Sex hormone testing: Generally not indicated unless clinical signs of virilization present 2
Imaging Evaluation
MRI is the preferred imaging modality to characterize tissue composition and guide treatment planning 5:
- Distinguishes between four types:
- Type I: Dorsocervical fat pad (77.6% of cases)
- Type II: Dorsocervical fat accumulation (11.2%)
- Type III: Nuchodorsal lipoma (10.2%)
- Type IV: Mixed type (1%)
- Identifies degree of fibrosis, which impacts surgical approach 5, 8, 6
- Helps differentiate from other masses requiring different management
If adrenal incidentaloma discovered during workup: Follow guideline-directed evaluation with non-contrast CT to measure Hounsfield units and characterize the lesion 1, 2.
Common Pitfalls to Avoid
- Don't assume HIV association: Only 1 of 383 surgical patients in a recent series was HIV-positive 5
- Don't skip Cushing's screening: Even mild hypercortisolism can cause buffalo hump, and the combination with other conditions (e.g., hypogonadism) may amplify clinical manifestations 7
- Don't overlook new metabolic diagnoses: 25% of patients in one series were newly diagnosed with metabolic disease during buffalo hump evaluation 4
- Don't order adrenal imaging reflexively: Only pursue if biochemical screening suggests adrenal pathology
Algorithm Summary
- History/Physical → Document Cushing's features, HIV status, metabolic comorbidities, functional impairment
- Biochemical → 1 mg dexamethasone suppression test (all patients) + metabolic panel
- Imaging → MRI of neck to characterize tissue and guide surgical planning
- Conditional testing → Aldosterone/renin ratio if hypertensive; metanephrines if concerning features
- If Cushing's confirmed → Proceed with adrenal imaging and endocrine referral per guidelines 1, 2